Title of article
CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial
Author/Authors
Jintanat Ananworanich، نويسنده , , Angele Gayet-Ageron، نويسنده , , Michelle Le Braz، نويسنده , , Wisit Prasithsirikul، نويسنده , , Ploenchan Chetchotisakd، نويسنده , , Sasisopin Kiertiburanakul، نويسنده , , Warangkana Munsakul، نويسنده , , Phitsanu Raksakulkarn، نويسنده , , Somboon Tansuphasawasdikul، نويسنده , , Sunee Sirivichayakul، نويسنده , , Matthias Cavassini، نويسنده , , Urs K، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2007
Pages
7
From page
459
To page
465
Abstract
Background
Stopping antiretroviral therapy in patients with HIV-1 infection can reduce costs and side-effects, but carries the risk of increased immune suppression and emergence of resistance.
Methods
430 patients with CD4-positive T-lymphocyte (CD4) cou
Journal title
The Lancet
Serial Year
2007
Journal title
The Lancet
Record number
590039
Link To Document